Driven by an increasingly diverse and ageing population, coupled with a significant rise in risk factors such as hypertension and obesity, the projected costs associated with cardiovascular diseases (CVD) are set to triple by 2050, according to forecasts by the American Heart Association. This prediction highlights a potentially monumental health and economic burden, with an estimated 61% of US adults—more than 184 million people—expected to suffer from some form of CVD over the next three decades. This prevalence is anticipated to incur direct and indirect costs of $1.8 trillion.
The new projections, detailed in two presidential advisories published in the Association’s journal Circulation, build upon previous research to assess future CVD prevalence and economic impact trends. Over its century-long history, the American Heart Association has significantly reduced death rates from heart disease and stroke, achievements acknowledged as the organisation marks its centennial milestone. Despite these advancements, heart-related conditions remain the leading causes of death and disability in the US.
Karen E. Joynt Maddox, M.D., M.P.H., FAHA, chair of the advisory writing groups, emphasised the ongoing challenges CVD poses and the critical need to address future projections. The advisories aim to anticipate trends over the next 30 years and identify key areas requiring intervention to sustain progress. This proactive approach is essential in mitigating the forecasted increase in CVD cases and associated costs.
Cardiovascular disease encompasses a range of conditions, including coronary heart disease, stroke, hypertension, and heart failure. The prevalence of these conditions is expected to rise significantly, driven mainly by increases in high blood pressure, diabetes, and obesity across all age groups. Despite these concerning projections, positive shifts in health behaviours, such as a decline in smoking rates and improvements in physical activity levels, are noted, suggesting a growing awareness and commitment to healthier lifestyles.
Looking ahead, the demographic landscape of the US will play a pivotal role in shaping CVD trends. The ageing population, alongside demographic shifts towards more diverse racial and ethnic groups, underscores the need for targeted health strategies. Disparities in CVD prevalence and risk factors persist among different demographic groups, influenced by systemic factors, including socioeconomic status and access to healthcare.
The economic impact of CVD is projected to escalate dramatically, primarily due to soaring healthcare costs and lost productivity. Direct healthcare expenditures related to CVD are forecasted to quadruple, reflecting both inflationary pressures and the increasing prevalence of these conditions. Stroke, in particular, is anticipated to drive a significant portion of these costs, given its association with an ageing population and rising hypertension rates.
Dhruv S. Kazi, M.D., M.Sc., M.S., FAHA, vice-chair of the advisory writing groups, highlighted the urgency of strategic interventions to curb these rising costs and prevalence rates. Modelling scenarios suggest that targeted reductions in risk factors could yield substantial benefits, potentially averting millions of CVD events and deaths annually by 2050. These scenarios underscore the importance of early intervention and comprehensive healthcare policies aimed at prevention and treatment.
Looking towards the future, advancements in medical research and public health initiatives offer hope for reversing current trends in CVD. The development of innovative treatments and continued support for scientific discovery are crucial in tackling these challenges. Moreover, addressing broader social determinants of health, including poverty and structural racism, is essential to ensuring equitable access to healthcare and reducing disparities in CVD outcomes across diverse populations.
Nancy Brown, Chief Executive Officer of the American Heart Association, emphasised the organisation’s commitment to advancing cardiovascular health into its second century. She called for collaborative efforts across communities, industries, and policy-makers to implement practical solutions and improve health outcomes nationwide. This collective approach, bolstered by ongoing research and public engagement, aims to transform the trajectory of cardiovascular health in the US and beyond.
As the American Heart Association prepares to navigate the complexities of an evolving healthcare landscape, the focus remains on equipping individuals and communities with the tools needed to lead healthier lives. By addressing the root causes of CVD and investing in preventive strategies, there is potential to mitigate the projected burden and foster a future where cardiovascular health is optimised for all.
More information: Karen E. Joynt Maddox et al, Forecasting the Burden of Cardiovascular Disease and Stroke in the United States Through 2050—Prevalence of Risk Factors and Disease: A Presidential Advisory From the American Heart Association, Circulation. DOI: 10.1161/CIR.0000000000001256
Journal information: Circulation Provided by American Heart Association
